Position in RDY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,127,132
New position
Shares Held
146,800
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 238 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $404,370,158 across 20 Drug Manufacturers - Specialty & Generic names. RDY ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
268,370 | $145,410,917 | |
| 2 | VTRS |
Viatris Inc
|
8,555,180 | $135,856,258 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,024,724 | $42,044,425 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
608,376 | $15,434,499 | |
| 5 | EBS |
Emergent BioSolutions Inc.
|
1,695,851 | $14,211,231 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
642,014 | $12,955,842 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
344,500 | $12,470,900 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
76,400 | $8,475,816 |
All Filings in RDY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,127,132 | 146,800 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||